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Background: Evaluation of the prevalence and impact of headache on the preceding day (“headache yesterday”;
HY) is a new approach, allowing more precise estimation of headache-attributed burden without recall error.
The aim of the study was to estimate the national burden attributable to headache disorders in Russia by applying
measures of prevalence of HY and its impact on productivity and daily activities in the general population.
Methods: We interviewed a representative population-based sample face-to-face by visiting randomly selected
households throughout Russia. We randomly selected one adult aged 18–65 years from each. We followed a
structured questionnaire including diagnostic questions, enquiry into occurrence of HY and various aspects of
attributed burden.
Results: Participation rate was 74.3%. One in seven participants (14.5%; men 9.1%: women 19.3%) reported HY.
Approximately half of these had one of the subtypes of headache occurring on ≥15 days/month; the remainder
had episodic migraine or tension-type headache almost equally. Mean duration of headache was 6.0 ± 4.4 hours. In
88.3% headache intensity was moderate or severe (mean 2.1 on a scale 1–3) and in 73.9% HY impaired daily activity.
Loss of productivity at work due to headache totalled 2.6 million person-years/year, or 4.0% of workforce capacity.
This estimate exceeded by 70% a previous estimate from the same survey based on recall over the preceding
3 months. There was greater impact on other daily activities.
Conclusion: Recall-error-free estimation shows lost productivity every day due to headache in the Russian
population is enormously high. Measures to redress these losses – effective structured health-care services
supported by educational programmes – should be seen as a public-health priority while almost certainly being
cost-saving.
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The Global Burden of Disease Survey 2010 (GBD2010)
ranked tension-type headache (TTH) and migraine as
the second and third most common diseases worldwide
[1]. More importantly, these primary headache disorders
are associated with disability, reduced quality of life,
public ill health and high economic burdens on both
individual and population levels. Migraine has been re-
cognized as the seventh highest among specific causes of
disability worldwide [1,2]. The costs of headache disor-
ders are enormous: estimated in 2012 at well in excess
of EUR 100 billion per year in the European Union [3].
In the last 20 years a large number of population-based
studies of headache prevalence have been performed,
especially in the United States of America and Western
Europe [4]. Some have also estimated headache-attributed
burden, and those assessing socioeconomic impact have
employed questionnaires such as the Migraine Disability
Assessment (MIDAS) instrument [5] or its derivative, the
Headache-Attributed Lost Time (HALT) questionnaire
[5,6]. The former, and in its original form (HALT-90) also
the latter, depend upon enquiry relating to the three
months prior to the interview, an approach subject to the
limitations and errors (and possible biases) of recall over
such a long period [7]. The consequences of these limita-
tions, errors and possible biases need to be considered,
and an alternative approach that allows this is enquiry into
headache occurring on the day before the interview
(“headache yesterday”; HY). Recall of HY and its impact is
likely to be highly reliable. While what happened yesterday
is not indicative of headache-attributed burden in indivi-
duals, at population level it is. Such an approach does,
however, require a high number of respondents, since far
fewer people have headache yesterday than the number
who have headache in 3 months. Furthermore, diagnosis
cannot reliably be based on a single headache episode;
unless a respondent can report that HY is typical of a re-
current headache that has been diagnosed, its nature will
not be known.
A question subset concerning HY [8,9], has been in-
cluded into several recent large epidemiological studies
supported by Lifting The Burden and conducted within the
Global Campaign against Headache, including those in
China [10], India [11], Pakistan [12], Nepal [13], Zambia
(unpublished) and countries of the Eurolight project [7].
Here we report the analysis of HY in Russia. We apply
this analysis in making an estimate of the national socio-
economic burden attributable to headache disorders,
and compare this to the estimate based on 3-months’
recall [14].
Methods
The methods of the study have been described in detail
previously [15] and are only summarised here.Ethics
The study protocol was approved by the ethics com-
mittee of the Russian Academy of Sciences. All partici-
pants were informed of the purpose of the survey and
gave verbal consent.
Sampling
This nationwide cross-sectional survey of the working-
age population (18–65 years) included 44 settlements of
six of the seven Federal Districts of Russia. The inhabi-
tants of the seventh, Far-East region (approximately 6%
of the total population) were not included owing to its
very low population density and geographical seclusion.
In order to achieve a representative sample of the coun-
try’s population, we performed hierarchical cluster sam-
pling. Within clusters we made a random selection of
households, which we visited unannounced, selecting for
interview only one person per household, also randomly.
Enquiry
Face-to-face interviews were conducted by trained non-
medical interviewers employed by the Russian Institute
of Sociology using a structured questionnaire. To reduce
possible interest bias, potential respondents were asked
if they would take part in a short interview of the
Russian Institute of Sociology and were not informed of
the focus of the survey before they agreed (although they
could stop the interview later).
The questionnaire developed by Lifting The Burden [9]
was adapted, translated into the Russian language
and validated as reported previously [16]. This modular
questionnaire included demographic enquiry and head-
ache screening questions and, for those with headache in
the last year, diagnostic questions based on ICHD-II cri-
teria [17] and enquiry into various aspects of headache-
attributed burden (including the HALT questionnaire).
Questions on HY included duration of HY (in hours up to
24), intensity of HY (graded as “mild”, “moderate” or
“severe”), usage of acute medications, lost productivity be-
cause of HY (could do “everything”, “more than half”, “less
than half” or “nothing” of what had been planned), impact
of HY in limiting daily activity (“complete”, “partial” or
“none”).
Statistics
We used statistics descriptively, calculating means, stan-
dard deviations (SDs) and medians as appropriate. We
used Pearson’s chi-squared to test differences between
proportions for significance.
Results
Demographic characteristics and 1-year prevalence
Of 2,725 contacted eligible persons, 2,025 (74.3%) agreed
to participate in the study and gave consistent answers.
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ting to know the topic of the survey, and 112 (4.1%)
interrupted the interview or gave unusable answers.
These were classed as non-participants. The participat-
ing sample were aged 39.5 (SD ± 13.4) years, compared
with the national population mean of 39.2 years, and
47.4% were male (nationally 46.6%). Other demographic
characteristics also revealed no differences between the
study sample and the general population [15]. As pre-
viously reported, the overall 1-year prevalence of head-
ache was 62.9%: 20.3% fulfilled ICHD-II criteria [17] for
episodic migraine (definite or probable), 30.9% for epi-
sodic TTH (definite or probable), 10.5% had headache
on ≥15 days/month and 1.1% had unclassified episodic
headaches [15].
Headache yesterday
HY was reported by 293 participants, representing a
1-day prevalence of 14.5% (CI 95%: 13.0 - 16.0), and by
approximately twice as many women as men (19.3% vs.
9.1%). This matched almost exactly the predicted 1-day
prevalence of 14.6% based on 1-year prevalence and
mean frequency in headache days/month (extrapolated
from the last 3 months) (Table 1). HY was reported to
be typical of their usual most bothersome (diagnosed)
headache by 93.5% of participants (males 95.4%, females
92.7%). Ignoring the diagnoses of the remaining 6.5%,
we found HY to be due more or less equally to episodic
migraine (24.9%) and episodic TTH (24.2%), each re-
sponsible for a quarter of cases and eclipsed by the vari-
ous causes of headache on ≥15 days/month, which were
responsible for twice as many (49.5%; Table 1). Thus mi-
graine and TTH yesterday were each reported by about
3.5% of the total sample, and these numbers also were
matched by the predicted 1-day prevalences of these
headache types (Table 1).
Mean duration of HY was 6.0 ± 4.4 hours. Over half
of participants (52.2%) reported headache duration of
<4 hours, probably explained by the widespread usage of
acute medications: 51.7% of participants with HY (or
7.3% of the total survey population) took such medica-
tions (Table 2). Approximately half of these took simple
analgesics and another half took combination analgesics;Table 1 Headache yesterday according to diagnosis, and com
reported frequency and 1-year prevalence





All headache 100.0 14.5
Episodic migraine 24.9 3.6
Episodic TTH 24.2 3.5
Headache on ≥15 days/month 49.5 7.2only one of 286 participants reported taking a triptan.
Nonetheless, almost one third of participants reported
headache effectively lasting throughout the whole day.
Headache intensity was moderate or severe in 88.2% of
participants; we graded “mild”, “moderate” and “severe”
on a scale 1–3, treated these values as continuous data
and derived a mean intensity of 2.1 ± 0.6. HY limited
daily activities in 73.9% of participants, completely so in
22.9%. Lost productivity due to HY was reported by
69.9% of participants with HY: 24.2% could do less than
half of what they had planned and 15.6% could do no-
thing. The analysis of HALT (and MIDAS) offsets those
who could do less than half against those who could do
more than half, counting the former as doing nothing
and the latter as doing everything [6]. Applying this con-
cept, we found that in total HY cost those affected 39.8%
of their productivity yesterday.
Despite the two-fold difference in prevalence, we saw
no significant differences in headache duration or inten-
sity, in functional impairment or lost productivity, or in
use of medication between men and women (Table 2).
Although all 2,025 participants were of working age,
some were students (n = 100), some retired (n = 237) and
some gave no answer concerning their employment status
(n = 85). Lost productivity was especially high (54.0%)
among retired participants with HY. For purposes of ana-
lysis we regarded all 1,603 other participants as potential
workers, and categorized them as employed for money
(including self-employed; n = 1,356) or unemployed (in-
cluding housewives; n = 247) (Table 3). We analyzed lost
productivity separately for employed and unemployed par-
ticipants, and, in the case of the former, for those for
whom yesterday had been a workday (54.9%) or a free day
(45.1%). There were differences, though not statistically
significant: 11.9% of employed participants reported HY
(11.6% with a workday, 12.4% with a free day yesterday)
compared with 15.4% of unemployed (Pearson’s chi-
squared = 2.26; P = 0.13). Among those with HY for whom
yesterday had been a workday, 34.1% of productivity was
lost (23.9% able to perform less than half and 10.2% noth-
ing because of HY). Approximately one third (30.7%)
could do everything and another third (35.2%) more than








62.9 7.1 ± 8.3 14.6
20.3 4.4 ± 3.5 2.9
30.9 3.5 ± 3.1 3.5
10.5 23.1 ± 6.7 8.0
Table 2 Burden of headache yesterday by gender
Burden variable All Males Females
Duration of HY (hr)







<1 hr (%) 13.0 11.5 13.6
1-4 hr (%) 39.2 42.5 37.9
5-12 hr (%) 16.4 12.6 18.0
>12 hr (%) 31.4 33.3 30.6
Intensity of HY (%)
Mild pain 11.7 12.6 11.3
Moderate pain 63.4 61.0 64.5
Severe pain 24.8 26.4 24.1
Limitation of daily
activities (%)
None 26.0 28.7 24.9
Partial 51.0 48.3 52.2
Complete 22.9 23.0 22.9
Lost productivity (%)
None 30.1 33.3 28.7
Did >50% of expected 30.1 23.0 33.2
Did <50% of expected 24.2 26.4 23.3




Simple analgesics 51.3 55.8 49.5
Combination analgesics 48.0 44.1 49.5
caffeine-containing 48.0 44.1 49.5
codeine-containing 16.9 16.8 17.1
barbiturate-containing 15.5 16.8 15.2
Triptans 0.7 0 1.0
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a workday (34.1%) or free day (35.2%) yesterday and those
unemployed (36.9%); however, those with a free day were
slightly, and those unemployed very markedly, more likely
to report that they did nothing rather than less than half





(N = 1,603) (n = 1,356)
Reporting HY, n (%) 200 (12.5) 162 (11.9)
Lost productivity due to HY (%)
none (did everything as planned) 34.5 34.0
did >50% of expected 30.5 31.4
did <50% of expected 20.8 23.3
did nothing 14.2 11.3
*The term “potential workers” excludes students, retirees and participants who gaveWe calculated headache-attributed lost productivity
among those who worked yesterday as the product of per-
person loss productivity (34.1%) and prevalence of HY
(11.6%), arriving at 4.0%, representing the lost productivity
in the workforce on every workday. Using the same ap-
proach for participants for whom yesterday was not a
workday (employed with a free day, or unemployed), we
discovered higher losses: 4.4% and 5.7% respectively. In
other words, less productivity was lost from worktime
than from household work and other activities.
The two-fold difference in prevalence between genders
remained stable in employed participants with a work-
day yesterday (women 16.4%, men 7.5%).
Discussion
This is the third published analysis of headache yesterday
(HY) worldwide, following those in China [10] and eight
countries of Europe [7], and the first in Russia. It is of
some interest to know the proportion of a population
afflicted by headache on any day, but the true value of this
population-based enquiry lies in its almost complete de-
tachment from the recall errors to which traditional
burden-of-headache surveys are so strongly subject. This
approach was pioneered by Lifting The Burden in its
Global Campaign against Headache [18,19] and is in-
cluded in the Headache-Attributed Restriction, Disability,
Social Handicap and Impaired Participation (HARDSHIP)
questionnaire recently developed for population-based
studies of headache [8,9].
In our study, 14.5% of participants, aged 18–65 years
(i.e., of working age), reported HY. Extrapolated to the
entire population, this means that approximately every
seventh person of working age in the country suffers
from headache on any and every day. This finding is
quite similar to the 15-19% reported from 15 countries
in Europe [7], although these data from the Eurolight
study were not entirely population-based. In absolute
numbers, in Russia’s total population of 142 million,
there are 99.8 million adults aged 18–65 years [20]
among whom, on any and every day, there are 14.5 million






(n = 768) (n = 588) (n = 247)





no answer concerning their employment status (see text).
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our 1-year headache prevalence study [15], we found by
prediction the same result – 14.6% of the adult population
with headache every day. Interestingly, in both earlier
published studies of HY, similar internal consistency was
seen between reported HY and predicted 1-day prevalence
of headache based on recalled frequency during the pre-
ceding 3 months [7,10]. In our study, the fact that well
over 90% of participants reported HY to be typical of their
most bothersome (and therefore diagnosed) headache
allowed us to analyze HY according to headache type. For
each – episodic migraine, episodic TTH and headache
on ≥15 days/month – quite similar consistency was
observed.
Headache on ≥15 days/month is highly prevalent (10.5%)
in Russia [15]. In accordance with this, the various causes
of headache on ≥15 days/month accounted for almost 50%
of cases of HY, confirming their importance as contribu-
tors to population ill health and disability in Russia [14].
Almost 52% of those with HY took acute headache medica-
tions, which extrapolates to 7.5 (14.5 × 0.52) million people
doing so every day. Almost half of these (48%, extrapolat-
ing to 3.6 million people) used combination analgesics,
medications probably closely associated with medication-
overuse headache (MOH) [21]. In Russia, medication
overuse was also reported by two thirds of survey partici-
pants with headache on ≥15 days/month [15], and their
diagnosis was probable MOH.
The main purpose of this survey was a correct evalu-
ation of headache-attributed burden. The mean duration
of HY of 6 hours was relatively short – reflecting prob-
ably the effect of treatment – but in line with duration
reported in the European study [7] and slightly more
than was found in China [10]. From this mean duration
and the prevalence of HY, we calculate that 3.6% of the
population aged 18–65, or 3.6 million adults, have head-
ache at any one time. This proportion is quite similar to
the 4.0% in Europe (6) but double the 1.8% reported in
China [10]. In terms of pain intensity, the mean was 2.1
on a scale of 1–3, expected to be disabling. A quarter of
participants (24.8%) described severe headache, and ap-
proximately the same proportion (22.9%) reported that
their daily activities were reduced to nil by HY (Table 2).
In Russia’s 99.8 million people of working age [20], this
means about 3.5 million people so affected every day.
Since the indirect costs make up by far the greater part
of all headache-attributed costs [3,22], and in order
accurately to evaluate headache-attributed economic
burden, we concentrated on the working population. In
employed participants, the prevalence of HY was lower
(11.9%) without meaningful difference between those
who had a workday (11.6%) or a free day (12.4%) yester-
day, indicating that the phenomenon of “weekend head-
ache” has a minor effect at population level. Above, wecalculated a 4.0% lost productivity in the workforce on
every workday because of headache (see Results). Since
the total working population aged 18–65 years in Russia is
65.6 million [20], this means 2.62 million people unpro-
ductive every day or a loss of 2.62 million person-years/
year. This number is approximately 70% higher than the
1.54 million person-years/year estimated through recall
over the last 3 months [14]. Even more time was lost to
HY from household work or leisure. Household work is
generally more easily abandoned or delayed than paid
labour, so this finding was expected, and has been re-
ported in previous studies [14,23].
Although in Table 1 we present HY according to diag-
nosis (based on participants’ assertions in 93.5% of cases
that HY was typical of their diagnosed most bothersome
headache), because of the diagnostic uncertainty we did
not go beyond this to attribute burden to each headache
type. In terms of prevalence, approximately half of cases
of HY were one or another of the causes of headache on
≥15 days/month and a quarter were each of migraine
and TTH. Burden would depend, in particular, on how
disabling each headache type tended to be, with, on
average, migraine expected to be most and TTH least.
Headache on ≥15 days/month is variable in its effect; al-
though chronically disabling, it does not necessarily
cause a high level of disability because people develop
coping mechanisms for it. But it is worth recognizing
that about two thirds of headache on ≥15 days/month in
Russia (as in many other countries) is probably MOH
(14), an avoidable condition. Which, with this further
and explicit demonstration that headache not only
causes much ill health in Russia but costs the country a
substantial proportion of its gross domestic product,
raises the question of what should be done about all this.
The answer is urgent government investment in ad-
equate structured health care for headache, supported
by educational initiatives aimed both at health-care pro-
fessionals and at the general public (who include people
affected by headache) (13). The irony, while this does
not happen, is that it would almost certainly be cost-
saving [24].
The strengths of our study were several. Enquiry into
headache yesterday is a powerful approach to population-
based burden-of-headache studies, virtually eliminating
recall error and any bias that may follow from it. Through
face-to-face interviews we achieved a comparatively low
non-participation rate of 25.7%, and could avoid the previ-
ously described bias of “headache today”: participants with
headache on the day they receive the questionnaire by
post may defer responding until headache-free, and then
spuriously report HY [7]. Since household visits were un-
announced and potential respondents were not informed
about the survey topic, we believe we had little interest
bias (due only to interruption of interviews after they had
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population demographically owing to multi-stage cluster
sampling. As to limitations, we did not specifically enquire
into absenteeism from work yesterday, estimating lost
productivity from reports of what had been done in rela-
tion to what had been planned. Arguably this served a
more conservative analysis; certainly it could not lead to
an overestimate of lost productivity at work.
Conclusion
In conclusion, using HY as a method of enquiry free from
recall error, we confirm a very high level of headache-
attributed burden in Russia. We repeat our call to the
government for action [14], observing that correct action
would almost certainly be cost-saving [24].
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